The results revealed that the pathways related to tumor progression, such as hypertrophic cardiomyopathy-related genes, the extracellular matrix-receptor interaction pathway, and the TGF-β signaling pathway, were significantly enriched in the high DLX5 expression group (Fig. 3E). Here, DLX5 is linked to hypertrophic cardiomyopathy.